Status:

COMPLETED

Exercise in Older Adults at Risk for Type 2 Diabetes

Lead Sponsor:

Western University, Canada

Conditions:

Cognitive Change

Eligibility:

All Genders

60-80 years

Phase:

NA

Brief Summary

Older adults with type 2 diabetes experience neurocognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (i.e., those who a...

Detailed Description

The effects of exercise on cognition and brain structure in older adults at risk for type 2 diabetes: A 3T MRI study Objectives/research questions: In this study the research questions included: 1....

Eligibility Criteria

Inclusion

  • Community-dwelling
  • Aged 60-80 years
  • "At-risk" for diabetes, where they have one of the following: i) blood glucose level of 6.1-7 mmol/L, ii) body mass index \> 25, or iii) score \> 21 on the CANRISK diabetes questionnaire
  • Score \> 24/30 on MMSE
  • Score \> 6/8 on the IADL scale
  • Visual acuity of at least 20/40, with or without corrective lenses
  • Speak and understand English fluently
  • Complete the PAR-Q
  • Obtain physician's clearance to start a supervised exercise program

Exclusion

  • Current medical condition for which exercise is contraindicated
  • Participated regularly in resistance or aerobic training in the last 6 months
  • Diagnosed with neurodegenerative disease (including dementia, Alzheimer's disease, or Parkinson's disease)
  • Experienced a vascular incident (e.g., stroke, myocardial infarction)
  • Diagnosed with a psychiatric condition
  • Untreated depression and scored 5 or less on the Geriatric Depression Scale
  • Currently on hormone replacement therapy
  • Clinically significant peripheral neuropathy or severe musculoskeletal or joint disease
  • Currently taking psychotropic medications
  • Cannot blood draw

Key Trial Info

Start Date :

September 23 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 5 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05229705

Start Date

September 23 2022

End Date

June 5 2024

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Western University

London, Ontario, Canada, N6A 5B7